You are here: Home » Companies » News
Business Standard

Zydus gets USFDA nod for drugs treating fungal infections, skin disorder

Company will manufacture Fluconazole tablets at its Baddi facility

Press Trust of India  |  New Delhi 

Drug firm Zydus Cadila has received the final approval from the US health regulator for its Fluconazole tablets and Clobetasol Propionate spray. The company has received "final approval from the United States Food and Drug Administration (USFDA) to market Fluconazole tablets USP in strengths of 50 mg, 100 mg, 150 mg and 200 mg and Clobetasol Propionate Spray 0.05 per cent", Cadila Healthcare said in a filing to BSE. Fluconazole tablets are used to treat fungal infections. They will be produced at the group's manufacturing facility at Baddi, it ...

TO READ THE FULL STORY, SUBSCRIBE NOW AT JUST Rs 149 A MONTH

Key stories on business-standard.com are available to premium subscribers only.

LOGIN

EMAIL / USER NAME
PASSWORD
REMEMBER ME Forgot password?

Not a member yet ? Resister Now

Connect using any below

  • Don't lose the opportunity of saving $26.77 per month
  • Don't lose the opportunity of saving $26.77 per month
Total Amount
Rs. 0.00
To proceed, kindly select a subscription package

WHAT YOU GET

On Business Standard Digital

  • Access your subscription from anywhere. Be it your computer, tablet or smartphone using a browser or the App, Your Choice.
  • Access to exclusive content, features, opinions and comment, hand-picked by our editors, just for you.
  • Pick your 5 favourite companies. Get all the news upates at the end of each day through E-Mail.
  • Pick the industry that you want to track. And get a daily news letter specific to that industry. Cut out the clutter.
  • And stay on top of your investments. Track stock prices in your portfolio
  • Access 18 years of archival data

On Digital

  • Seamless access to WSJ.com with your Business Standard digital account.
  • Experience the best of the Journal's reporting, video and interactive features.
  • Read about the people and events shaping business, finance, technology, politics, technology and culture.
  • Stay informed with newsletters - an easy way to get WSJ content straight to your inbox - making life easier on your busiest days.
  • More business executives read the Journal globally than any other publication.
*Note :
Our Partners are proud to be associated with this initiative and will contribute Rs 100 x 6 months thereafter, standard rate of Rs 149 will be charged.
Offer valid for Indian residents only
Requires you to share personal information like PAN, Date of Birth, and Income.
*Annual saving on WSJ subscription price of US$ 347.88 (12 months @ US$ 28.99 per month)
* 1US$ = 67.50 INR.
*Please note that this offer is not valid if you are/were a registered/existing user on WSJ Digital
RECOMMENDED FOR YOU

Zydus gets USFDA nod for drugs treating fungal infections, skin disorder

Company will manufacture Fluconazole tablets at its Baddi facility

Company will manufacture Fluconazole tablets at its Baddi facility Drug firm Zydus Cadila has received the final approval from the US health regulator for its Fluconazole tablets and Clobetasol Propionate spray. The company has received "final approval from the United States Food and Drug Administration (USFDA) to market Fluconazole tablets USP in strengths of 50 mg, 100 mg, 150 mg and 200 mg and Clobetasol Propionate Spray 0.05 per cent", Cadila Healthcare said in a filing to BSE. Fluconazole tablets are used to treat fungal infections. They will be produced at the group's manufacturing facility at Baddi, it ... image
Business Standard
177 22

Zydus gets USFDA nod for drugs treating fungal infections, skin disorder

Company will manufacture Fluconazole tablets at its Baddi facility

Drug firm Zydus Cadila has received the final approval from the US health regulator for its Fluconazole tablets and Clobetasol Propionate spray. The company has received "final approval from the United States Food and Drug Administration (USFDA) to market Fluconazole tablets USP in strengths of 50 mg, 100 mg, 150 mg and 200 mg and Clobetasol Propionate Spray 0.05 per cent", Cadila Healthcare said in a filing to BSE. Fluconazole tablets are used to treat fungal infections. They will be produced at the group's manufacturing facility at Baddi, it ...

image
Business Standard
177 22